| abstract |
The present invention relates to a liquid crystal medium comprising a compound of formula (I) and/or at least one genetically positive compound of Tinuvin 770®, optionally at least one further genetically positive compound, and optionally at least one further genetically neutral compound: , And liquid crystal displays comprising these media, in particular active-matrix displays and in particular TN, IPS and FFS displays: In the above formula, the variables have their respective meanings described in the specification. |